Steve DiPalma

Steve DiPalma

Steve is a well-established leader with more than 30 years of experience in life sciences and healthcare. He has served as a CFO, CEO and COO to companies ranging from venture-backed start-ups to subsidiaries of Fortune 100 firms and publicly traded entities. In these roles, he had responsibility for finance and accounting, human resources, information technology and facilities, and played a key role in business development and strategic planning. He was formerly Chairman of Cognoptix and currently serves on the board of Phytera.

Steve holds a BS from the University of Massachusetts and MBA from Babson College.

Select Achievements

  • Managed IPOs, follow-ons, reverse mergers and SPAC transactions as an in-house or consulting CFO
  • Co-founded and led two successful diagnostics start-ups
  • Participated in the successful reorganization of Cambridge Biotech from Chapter 11 bankruptcy protection into Aquila BioPharmaceuticals


Strategic planning and operational management
Corporate and business development
IPO preparation
International fundraising and corporate structuring
Mergers and acquisitions